德国的预先研究指令:披露标准的建议

IF 0.8 Q4 PSYCHOLOGY, DEVELOPMENTAL
M. Scholten, A. Gieselmann, J. Gather, J. Vollmann
{"title":"德国的预先研究指令:披露标准的建议","authors":"M. Scholten, A. Gieselmann, J. Gather, J. Vollmann","doi":"10.1024/1662-9647/a000184","DOIUrl":null,"url":null,"abstract":"The fourth amendment to the German Medicinal Products Act (Arzneimittelgesetz) states that nontherapeutic research in incompetent populations is permissible under the condition that potential research participants expressly declare their wish to participate in scientific research in an advance research directive. This article explores the implementation of advance research directives in Germany against the background of the international legal and ethical framework for biomedical research. In particular, it addresses a practical problem that arises from the disclosure requirement for advance research directives. We show that, if the disclosure standard for advance research directives is set at a token level, nontherapeutic research in incompetent populations becomes practically impossible. To resolve this issue, we suggest the disclosure standard be set at a type level.","PeriodicalId":45525,"journal":{"name":"GeroPsych-The Journal of Gerontopsychology and Geriatric Psychiatry","volume":null,"pages":null},"PeriodicalIF":0.8000,"publicationDate":"2018-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":"{\"title\":\"Advance Research Directives in Germany: A Proposal for a Disclosure Standard\",\"authors\":\"M. Scholten, A. Gieselmann, J. Gather, J. Vollmann\",\"doi\":\"10.1024/1662-9647/a000184\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The fourth amendment to the German Medicinal Products Act (Arzneimittelgesetz) states that nontherapeutic research in incompetent populations is permissible under the condition that potential research participants expressly declare their wish to participate in scientific research in an advance research directive. This article explores the implementation of advance research directives in Germany against the background of the international legal and ethical framework for biomedical research. In particular, it addresses a practical problem that arises from the disclosure requirement for advance research directives. We show that, if the disclosure standard for advance research directives is set at a token level, nontherapeutic research in incompetent populations becomes practically impossible. To resolve this issue, we suggest the disclosure standard be set at a type level.\",\"PeriodicalId\":45525,\"journal\":{\"name\":\"GeroPsych-The Journal of Gerontopsychology and Geriatric Psychiatry\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2018-05-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"GeroPsych-The Journal of Gerontopsychology and Geriatric Psychiatry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1024/1662-9647/a000184\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PSYCHOLOGY, DEVELOPMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"GeroPsych-The Journal of Gerontopsychology and Geriatric Psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1024/1662-9647/a000184","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PSYCHOLOGY, DEVELOPMENTAL","Score":null,"Total":0}
引用次数: 6

摘要

《德国药品法》(Arzneimittelgesetz)第四修正案规定,在潜在的研究参与者明确声明他们希望在预先研究指令中参与科学研究的情况下,允许在不合格人群中进行非治疗性研究。本文探讨了在生物医学研究的国际法律和伦理框架的背景下,在德国实施先进的研究指令。特别地,它解决了一个实际问题,这是由于事先研究指令的披露要求而产生的。我们表明,如果预先研究指令的披露标准设定在一个象征性的水平上,在不称职的人群中进行非治疗性研究实际上是不可能的。为了解决这个问题,我们建议将披露标准设置为类型级别。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Advance Research Directives in Germany: A Proposal for a Disclosure Standard
The fourth amendment to the German Medicinal Products Act (Arzneimittelgesetz) states that nontherapeutic research in incompetent populations is permissible under the condition that potential research participants expressly declare their wish to participate in scientific research in an advance research directive. This article explores the implementation of advance research directives in Germany against the background of the international legal and ethical framework for biomedical research. In particular, it addresses a practical problem that arises from the disclosure requirement for advance research directives. We show that, if the disclosure standard for advance research directives is set at a token level, nontherapeutic research in incompetent populations becomes practically impossible. To resolve this issue, we suggest the disclosure standard be set at a type level.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.00
自引率
0.00%
发文量
30
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信